P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE

Objectives: Autosomal dominant polycystic kidney disease (ADPKD) is due to mutations in genes PKD1 and PKD2 encoding polycystin-1 and -2, which transduce flow variations into cellular signals in the renal epithelium but also in vascular endothelium. However, the impact of polycystin deficiency on th...

Full description

Bibliographic Details
Main Authors: A. Lorthioir, R. Joannidès, I. Rémy-Jouet, C. Fréguin-Bouilland, M. Iacob, C. Monteil, D. Lucas, M.P. Audrezet, D. Guerrot, V. Richard, C. Thuillez, M. Godin, J. Bellien
Format: Article
Language:English
Published: Atlantis Press 2013-11-01
Series:Artery Research
Online Access:https://www.atlantis-press.com/article/125939021/view
id doaj-cb2a46650cc145418a9d5407a85393e6
record_format Article
spelling doaj-cb2a46650cc145418a9d5407a85393e62020-11-25T03:16:25ZengAtlantis PressArtery Research 1876-44012013-11-0171010.1016/j.artres.2013.10.124P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINEA. LorthioirR. JoannidèsI. Rémy-JouetC. Fréguin-BouillandM. IacobC. MonteilD. LucasM.P. AudrezetD. GuerrotV. RichardC. ThuillezM. GodinJ. BellienObjectives: Autosomal dominant polycystic kidney disease (ADPKD) is due to mutations in genes PKD1 and PKD2 encoding polycystin-1 and -2, which transduce flow variations into cellular signals in the renal epithelium but also in vascular endothelium. However, the impact of polycystin deficiency on the release of endothelium-derived factors during flow variations is unknown. Methods: In 21 normotensive ADPKD patients with normal kidney function and 21 control subjects, radial artery diameter and blood flow were measured during hand skin heating and post-ischemic hyperaemia. Local blood samples were drawn during heating to quantify plasma nitrite, indicator of nitric oxide (NO) availability, epoxyeicosatrienoic acids (EETs) and endothelin-1. Results: Basal inflammatory and oxidative stress markers were similar between groups. Flow-mediated dilatation was lower in ADPKD patients than in controls during heating (16.1±1.1 vs. 23.2±1.0%), as confirmed by their downward shift of the diameter-shear stress relationship, but not during post-ischemic hypaeremia, and without difference in endothelium-independent dilatation to glyceryl trinitrate. Nitrite increased during heating in controls but not in patients (30±10 vs. −16±8 nmol/L). Plasma EETs tended to increase in controls but not in patients, without difference in endothelin-1 reduction. Intra-brachial infusion of dopamine (0.25–0.5 mg/kg/min) during heating induced a dose-dependent upward shift of the diameter-shear stress relationship in ADPKD patients and restoration of NO release. Conclusions: ADPKD patients display a loss of NO release and subsequent reduction in endothelium-dependent dilatation during sustained flow increase. The prevention of this alteration by dopamine may help to reduce the high prevalence of cardiovascular diseases in ADPKD.https://www.atlantis-press.com/article/125939021/view
collection DOAJ
language English
format Article
sources DOAJ
author A. Lorthioir
R. Joannidès
I. Rémy-Jouet
C. Fréguin-Bouilland
M. Iacob
C. Monteil
D. Lucas
M.P. Audrezet
D. Guerrot
V. Richard
C. Thuillez
M. Godin
J. Bellien
spellingShingle A. Lorthioir
R. Joannidès
I. Rémy-Jouet
C. Fréguin-Bouilland
M. Iacob
C. Monteil
D. Lucas
M.P. Audrezet
D. Guerrot
V. Richard
C. Thuillez
M. Godin
J. Bellien
P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE
Artery Research
author_facet A. Lorthioir
R. Joannidès
I. Rémy-Jouet
C. Fréguin-Bouilland
M. Iacob
C. Monteil
D. Lucas
M.P. Audrezet
D. Guerrot
V. Richard
C. Thuillez
M. Godin
J. Bellien
author_sort A. Lorthioir
title P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE
title_short P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE
title_full P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE
title_fullStr P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE
title_full_unstemmed P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE
title_sort p4.05 polycystin deficiency results in complete loss of no synthesis during sustained flow-mediated dilatation of conduit arteries in autosomal dominant polycystic kidney disease: possible reversal by dopamine
publisher Atlantis Press
series Artery Research
issn 1876-4401
publishDate 2013-11-01
description Objectives: Autosomal dominant polycystic kidney disease (ADPKD) is due to mutations in genes PKD1 and PKD2 encoding polycystin-1 and -2, which transduce flow variations into cellular signals in the renal epithelium but also in vascular endothelium. However, the impact of polycystin deficiency on the release of endothelium-derived factors during flow variations is unknown. Methods: In 21 normotensive ADPKD patients with normal kidney function and 21 control subjects, radial artery diameter and blood flow were measured during hand skin heating and post-ischemic hyperaemia. Local blood samples were drawn during heating to quantify plasma nitrite, indicator of nitric oxide (NO) availability, epoxyeicosatrienoic acids (EETs) and endothelin-1. Results: Basal inflammatory and oxidative stress markers were similar between groups. Flow-mediated dilatation was lower in ADPKD patients than in controls during heating (16.1±1.1 vs. 23.2±1.0%), as confirmed by their downward shift of the diameter-shear stress relationship, but not during post-ischemic hypaeremia, and without difference in endothelium-independent dilatation to glyceryl trinitrate. Nitrite increased during heating in controls but not in patients (30±10 vs. −16±8 nmol/L). Plasma EETs tended to increase in controls but not in patients, without difference in endothelin-1 reduction. Intra-brachial infusion of dopamine (0.25–0.5 mg/kg/min) during heating induced a dose-dependent upward shift of the diameter-shear stress relationship in ADPKD patients and restoration of NO release. Conclusions: ADPKD patients display a loss of NO release and subsequent reduction in endothelium-dependent dilatation during sustained flow increase. The prevention of this alteration by dopamine may help to reduce the high prevalence of cardiovascular diseases in ADPKD.
url https://www.atlantis-press.com/article/125939021/view
work_keys_str_mv AT alorthioir p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine
AT rjoannides p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine
AT iremyjouet p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine
AT cfreguinbouilland p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine
AT miacob p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine
AT cmonteil p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine
AT dlucas p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine
AT mpaudrezet p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine
AT dguerrot p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine
AT vrichard p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine
AT cthuillez p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine
AT mgodin p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine
AT jbellien p405polycystindeficiencyresultsincompletelossofnosynthesisduringsustainedflowmediateddilatationofconduitarteriesinautosomaldominantpolycystickidneydiseasepossiblereversalbydopamine
_version_ 1724636261756436480